- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Neuropathic pain
- Meeting Date: May 2022
- Public Summary Document (PSD) May 2022 PBAC Meeting - (PDF 370KB)
- Public Summary Document (PSD) May 2022 PBAC Meeting - (Word 40KB)
Pregabalin – May 2022
Pregabalin: Oral solution 20 mg per mL, 473 mL; Pregabalin AFT® - May 2022
Last updated
9 September 2022